Recruiting: WA
Summary: People with type 2 diabetes are more likely to develop cardiovascular disease. The COLCOT-T2D trial aims to evaluate the efficacy and safety of colchicine and non enteric-coated aspirin, used either in combination or alone, to improve cardiovascular outcomes in high-risk patients with type 2 diabetes.
GP requirements:
- Identify eligible patients
- Disseminate study information via letter or email
- Conduct baseline and 6-monthly visits (may be completed by a practice nurse or a Curtin University research nurse)
- Provide medical updates (with patient consent) for an approximately 3-year follow-up period
Participating GPs Receive:
- Up to $800 reimbursement per completed participant
- Site training and support